The omentum is the primary site of metastasis for ovarian cancer (OC). Interactions between cancer cells and adipocytes drive an invasive and prometastatic phenotype. Here we studied cancer cell-adipocyte crosstalk by using a direct coculture model with immortalized human visceral nondiabetic pre-adipocytes (VNPADs) and OC cells. We demonstrated increased proliferation, invasiveness, and resistance to cisplatin of cocultured compared with monocultured OC cells. RNA sequencing of OC cells from coculture versus monoculture revealed significant transcriptomic changes, identifying over 200 differentially expressed genes common to OVCAR5 and OVCAR8 cell lines. Enriched pathways included PI3K/AKT and complement activation. Lipid transfer into OC cells from adipocytes induced upregulation of complement C3 and C5 proteins. Inhibiting C3 or C5 reversed the invasive phenotype and C3 knockdown reduced tumor progression in vivo. Increased C3 expression was observed in omental implants compared with primary ovarian tumors and C3 secretion was higher in OC ascites from high-BMI versus low-BMI patients. C3 upregulation in OC cells involved activation of the ATF4-mediated integrated stress response (ISR). Overall, adipocyte-cancer cell interactions promoted invasiveness and tumorigenesis via lipid transfer, activating the ISR, and upregulating complement proteins C3 and C5.
Complement activation at the interface between adipocytes and cancer cells drives tumor progression.
脂肪细胞与癌细胞界面处的补体激活驱动肿瘤进展
阅读:10
作者:Valdivia Andres, Isac Ana Maria, Cardenas Horacio, Zhao Guangyuan, Zhang Yaqi, Huang Hao, Wei Jian-Jun, Cuello-Fredes Mauricio, Kato Sumie, Gómez-Valenzuela Fernán, Gourronc Francoise, Klingelhutz Aloysius, Matei Daniela
| 期刊: | JCI Insight | 影响因子: | 6.100 |
| 时间: | 2025 | 起止号: | 2025 Feb 18; 10(6):e184935 |
| doi: | 10.1172/jci.insight.184935 | 研究方向: | 细胞生物学、肿瘤 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
